160.70EUR0.00%Mkt Cap: 270.90B $P/E: 28.342d ago
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…
Industry Peers
Drug Manufacturers - General$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$190.75BUSDP/E 11.3
$183.02BUSD
$160.96BUSDP/E 37.2
$138.11BUSDP/E 14.9
$101.30BUSDP/E 24.0
$98.67BUSDP/E 16.3
$51.91BUSD
$32.74BUSDP/E 39.4
MRV
Marvell Technology, Inc.$26.57BUSDP/E 10.1
$12.10BUSDP/E 18.9
Key Statistics
Company
Market Cap270.90B $
Enterprise Value300.76B $
Revenue (TTM)66.70B $
Gross Profit52.29B $
Net Income (TTM)11.11B $
Revenue/Share43.03 USD
Last Price160.70 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees96.1K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)28.34
P/E (Forward)—
PEG1.56
EV/EBITDA13.90
EV/Revenue4.51
P/S4.06
P/B5.93
EPS (TTM)5.67
EPS (Forward)—
52W Range
—
52W High160.70 EUR
52W Low160.70 EUR
Profitability
Gross Margin81.90%
Oper. Margin23.46%
EBITDA Margin32.44%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth6.40%
Earnings Growth2.50%
Cash Flow & Leverage
Operating CF15.84B $
CapEx (TTM)6.42B $
FCF Margin7.99%
FCF Yield1.97%
Net Debt29.76B $
Net Debt/EBITDA1.38
Balance Sheet
Debt/Equity0.60
Current Ratio0.89
Quick Ratio0.66
Book Value/Sh27.11 EUR
Cash/Share3.203 EUR
Dividends
Fwd Div Rate2.720 EUR
Trail. Div Rate3.230 EUR
Div. Yield1.69%
5Y Avg Yield2.10%
Payout Ratio47.70%
Ex-Div DateAug 6, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions65.48%
Technical
SMA 50160.70 (-0.0%)
SMA 200160.70 (-0.0%)
Beta0.21
S&P 52W Chg20.80%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—